ChartRow logo
$418.72+0.52%
as of market close, Sep 11, 2026
☾ AH
PeersMRNALLYUNHJNJMRKABBV

ELV financial statements

The full income statement, balance sheet, and cash-flow statement for Elevance Health Inc. (ELV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 231.9M2024-09 231.9M2024-12 227.4M2025-03 225.9M2025-06 225.2M2025-09 222.2M2025-12 220.7M2026-03 217.2M2026-06 216.9M-6.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue199B+12.5%177B+3.3%171B+9.4%157B+13.0%139B+13.8%
Cost of revenue21.2B+7.2%19.8B+14.2%17.3B+32.7%13.0B+19.6%10.9B+21.7%
Selling, general & administrative21.0B+4.8%20.0B-0.3%20.1B+13.5%17.7B+11.2%15.9B-8.8%
Amortization of intangibles628M+8.3%580M-34.5%885M+15.4%767M+73.9%441M+22.2%
Operating income7.20B-8.4%7.86B-7.5%8.50B+2.6%8.28B+9.6%7.56B+18.9%
Interest expense1.40B+18.3%1.19B+15.0%1.03B+21.0%851M+6.6%798M+1.8%
Equity-method income398M+39700.0%1.00M+103.0%-33.0M-111.3%293M-47.9%562M+1002.0%
Gain (loss) on equity securities
-71.0M-136.6%
Pre-tax income6.71B-15.1%7.90B+2.4%7.71B+1.5%7.60B-4.9%8.00B+28.2%
Income tax1.05B-45.7%1.93B+12.1%1.72B+0.7%1.71B-7.3%1.85B+10.8%
5.66B-5.3%5.98B-0.1%5.99B+1.6%5.89B-4.3%6.16B+34.7%
Net income to non-controlling interest-1.00M+88.9%-9.00M-325.0%4.00M+166.7%-6.00M+33.3%-9.00M
$25.21-1.8%$25.68+1.8%$25.22+3.9%$24.28-2.7%$24.95+38.8%
EPS (basic)$25.28-2.1%$25.81+1.7%$25.38+3.3%$24.56-2.8%$25.26+38.6%
Weighted-avg shares (basic)224M-3.3%232M-1.8%236M-1.7%240M-1.6%244M-2.8%
Weighted-avg shares (diluted)225M-3.6%233M-1.9%237M-2.2%243M-1.6%247M-2.9%
Dividends per share$6.93+4.4%$6.63+12.0%$5.92+15.6%$5.12+13.3%$4.52+18.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
63.0B+6.9%58.9B-1.8%60.0B+7.9%55.6B+8.8%51.1B+11.7%
Cash & equivalents9.49B+14.5%8.29B+27.0%6.53B-11.7%7.39B+51.4%4.88B-15.0%
Other current assets5.34B+13.7%4.70B-18.9%5.79B+9.7%5.28B+13.5%4.65B+14.6%
121B+3.9%117B+7.3%109B+6.0%103B+5.4%97.5B+12.5%
Property, plant & equipment4.68B+0.6%4.65B+6.7%4.36B+1.0%4.32B+10.1%3.92B+12.5%
Operating lease right-of-use452M-20.3%567M-2.9%584M-3.3%604M-3.8%628M
Goodwill28.3B+0.2%28.3B+11.7%25.3B+3.8%24.4B+0.6%24.2B+11.7%
Intangible assets11.2B-7.4%12.1B+17.7%10.3B-0.4%10.3B-2.8%10.6B+12.9%
Other non-current assets2.31B+7.9%2.14B+8.8%1.97B+16.6%1.69B-1.6%1.72B+19.3%
41.0B+1.1%40.6B-2.9%41.8B+5.3%39.7B+13.8%34.9B+18.4%
Accrued liabilities7.32B+5.7%6.93B+0.2%6.91B+23.2%5.61B+12.8%4.97B-9.5%
Short-term & current debt1.10B-33.4%1.65B+0.0%1.65B+9.9%1.50B-6.2%1.60B+128.4%
Current lease liability131M-14.4%153M-6.7%164M-9.4%181M+36.1%133M
Other current liabilities10.3B+2.3%10.0B+1.4%9.89B+2.2%9.68B+23.4%7.85B+29.7%
77.5B+2.7%75.5B+8.5%69.5B+4.7%66.4B+8.4%61.3B+14.7%
Long-term debt30.8B+5.4%29.2B+25.7%23.2B+4.0%22.3B+5.6%21.2B+9.4%
Non-current lease liability529M-19.6%658M-3.9%685M-8.8%751M-13.1%864M
Operating lease liability (total)660M-18.6%811M-4.5%849M-8.9%932M-6.5%997M+4.2%
Deferred tax liabilities2.11B-1.8%2.15B+9.0%1.97B-2.2%2.02B-28.4%2.81B+39.4%
Other non-current liabilities3.53B+6.0%3.33B+91.4%1.74B+11.3%1.56B-7.2%1.68B-7.3%
43.9B+6.2%41.3B+5.1%39.3B+8.5%36.2B+0.4%36.1B+8.7%
Preferred stock0.000.000.000.000.00
Common stock2.00M+0.0%2.00M+0.0%2.00M+0.0%2.00M+0.0%2.00M-33.3%
Additional paid-in capital8.94B+0.3%8.91B+0.5%8.87B-2.4%9.08B-0.7%9.15B-1.0%
Retained earnings35.4B+5.5%33.5B+5.7%31.7B+7.1%29.6B+9.2%27.1B+14.0%
Accumulated other comprehensive income-451M+60.7%-1.15B+12.6%-1.31B+47.3%-2.49B-1164.0%-197M-231.3%
Non-controlling interest144M+29.7%111M+12.1%99.0M+13.8%87.0M+27.9%68.0M
Total equity incl. non-controlling44.0B+6.3%41.4B+5.1%39.4B+8.5%36.3B+0.5%36.1B+8.9%
Total liabilities & equity121B+3.9%117B+7.3%109B+6.0%103B+5.4%97.5B+12.5%
Common shares issued221M-3.0%227M-2.4%233M-2.1%238M-1.6%242M-1.5%
Common shares outstanding221M-3.0%227M-2.4%233M-2.1%238M-1.6%242M-1.5%
Shares outstanding (cover)221M-2.9%227M-2.3%233M-2.0%237M-1.6%241M-1.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.29B-26.1%5.81B-27.9%8.06B-4.0%8.40B+0.4%8.36B-21.7%
Depreciation & amortization1.55B+11.0%1.39B-20.2%1.75B+4.2%1.68B+28.6%1.30B+12.8%
Intangible amortization628M+8.3%580M-34.5%885M+15.4%767M+73.9%441M+22.2%
Share-based compensation276M+44.5%191M-33.9%289M+9.5%264M+3.5%255M-9.9%
Deferred income taxes-279M+25.4%-374M+37.9%-602M-423.5%-115M-133.6%342M+163.3%
-1.34B+74.0%-5.17B+7.3%-5.57B-22.2%-4.56B+52.7%-9.64B-31.6%
Capital expenditure1.12B-11.1%1.26B-3.1%1.30B+12.5%1.15B+6.0%1.09B+6.5%
Free cash flow3.17B-30.3%4.55B-32.7%6.76B-6.7%7.25B-0.4%7.28B-24.7%
Acquisitions-88.0M-101.8%4.81B+209.9%1.55B+139.1%649M-81.3%3.48B+75.9%
Purchases of investments15.0B-16.5%18.0B+10.8%16.2B-34.9%24.9B+33.6%18.7B-4.2%
Sales/maturities of investments1.77B-12.5%2.02B-31.1%2.94B-72.3%10.6B+144.5%4.34B-8.4%
Other investing activities0.00-100.0%124M+21.6%102M-15.0%120M+90.5%63.0M+40.0%
-1.74B-245.7%1.19B+135.6%-3.35B-154.1%-1.32B-411.6%423M+116.5%
Long-term debt issued2.99B-61.2%7.71B+199.5%2.57B-16.2%3.07B-11.3%3.46B+39.4%
Long-term debt repaid2.15B+30.1%1.65B-13.6%1.91B+0.5%1.90B+77.8%1.07B-44.7%
Common stock issued0.000.000.000.000.00
Common stock repurchased2.60B-10.2%2.90B+8.4%2.68B+15.5%2.32B+21.9%1.90B-29.6%
Dividends paid1.53B+1.4%1.51B+8.1%1.40B+13.5%1.23B+11.3%1.10B+15.7%
Other financing activities22.0M+1000.0%2.00M-71.4%7.00M-82.9%41.0M+51.9%27.0M+1250.0%
FX effect on cash-5.00M+16.7%-6.00M-500.0%-1.00M+92.9%-14.0M-40.0%-10.0M-242.9%
Net change in cash1.20B-34.2%1.83B+312.3%-861M-134.3%2.51B+391.2%-861M-207.1%
Interest paid1.41B+13.8%1.24B+20.1%1.03B+17.5%878M+6.8%822M+3.5%
Income taxes paid1.37B-3.1%1.41B-27.1%1.94B+21.5%1.59B+22.7%1.30B-27.4%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap77.4B-7.8%83.9B-24.3%111B-9.6%123B+9.5%112B+42.2%
P/E13.7×-2.6%14.0×-24.1%18.5×-6.2%19.7×+8.4%18.2×+5.6%
P/S0.4×-18.0%0.5×-27.9%0.7×-17.8%0.8×-0.9%0.8×+25.0%
P/B1.8×-13.1%2.0×-29.6%2.9×-15.1%3.4×+9.6%3.1×+30.8%
P/FCF24.4×+32.3%18.4×+37.1%13.4×+14.0%11.8×-23.3%15.4×+89.0%
Earnings yield7.3%+2.6%7.1%+31.8%5.4%+6.6%5.1%-7.8%5.5%-5.3%
FCF yield4.1%-24.4%5.4%-27.1%7.4%-12.3%8.5%+30.4%6.5%-47.1%
Dividend yield2.0%+9.9%1.8%+43.2%1.3%+25.8%1.00%+2.4%0.98%-17.6%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ELV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ELV filings on SEC EDGAR → Not investment advice.